Lotus Bio Valuation
| LBTD Stock | USD 0.01 0.00 0.00% |
Lotus Bio seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Lotus Bio Technology from analyzing the firm fundamentals such as Shares Outstanding of 782.77 M, price to earning of (1.71) X, and Return On Asset of -4.21 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Lotus Bio's price fluctuation is very steady at this time. Calculation of the real value of Lotus Bio Technology is based on 3 months time horizon. Increasing Lotus Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lotus pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Lotus Bio Technology Development. Since Lotus Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lotus Pink Sheet. However, Lotus Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.01 | Real 0.0084 | Hype 0.01 | Naive 0.01 |
The real value of Lotus Pink Sheet, also known as its intrinsic value, is the underlying worth of Lotus Bio Technology Company, which is reflected in its stock price. It is based on Lotus Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Lotus Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Lotus Bio Technology Development helps investors to forecast how Lotus pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lotus Bio more accurately as focusing exclusively on Lotus Bio's fundamentals will not take into account other important factors: Lotus Bio Total Value Analysis
Lotus Bio Technology Development is now anticipated to have valuation of 31.31 M with market capitalization of 13.78 M, debt of 16.68 K, and cash on hands of 1. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Lotus Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
31.31 M | 13.78 M | 16.68 K | 1 |
Lotus Bio Asset Utilization
One of the ways to look at asset utilization of Lotus is to check how much profit was generated for every dollar of assets it reports. Lotus Bio Technology Development secures a negative usage of assets of -4.21 %, losing $0.0421 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Lotus Bio Technology Development shows how discouraging it operates for each dollar spent on its assets.Lotus Bio Ownership Allocation
Lotus Bio Technology maintains a total of 782.77 Million outstanding shares. Lotus Bio Technology Development secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.4 % of Lotus Bio Technology Development outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Lotus Bio Profitability Analysis
Net Loss for the year was (19.55 K) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Lotus Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Lotus Bio and how it compares across the competition.
About Lotus Bio Valuation
The pink sheet valuation mechanism determines Lotus Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Lotus Bio. We calculate exposure to Lotus Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lotus Bio's related companies.Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.
8 Steps to conduct Lotus Bio's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lotus Bio's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lotus Bio's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Lotus Bio's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Lotus Bio's revenue streams: Identify Lotus Bio's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Lotus Bio's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Lotus Bio's growth potential: Evaluate Lotus Bio's management, business model, and growth potential.
- Determine Lotus Bio's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lotus Bio's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Lotus Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Lotus Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 82.8 M | |
| Retained Earnings | -948.9 K | |
| Shares Float | 249.1 M |
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Bio's price analysis, check to measure Lotus Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Bio is operating at the current time. Most of Lotus Bio's value examination focuses on studying past and present price action to predict the probability of Lotus Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Bio's price. Additionally, you may evaluate how the addition of Lotus Bio to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |